Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeah Jung

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Health Services Research|September 12, 2021
Measuring resource use in Medicare Advantage using Encounter dataJeah Jung, Caroline Carlin, Roger Feldman
The American Journal of Managed Care|June 19, 2019
Cancer care spending and use by site of provider-administered chemotherapy in MedicareAndrew Shooshtari, Yamini Kalidindi, Jeah Jung
The American Journal of Managed Care|October 17, 2018
The authors respond and stand behind their findingsYamini Kalidindi, Jeah Jung, Roger Feldman
Medical Care Research and Review : MCRR|August 5, 2023
Coding Intensity Through Health Risk Assessments and Chart Reviews in Medicare Advantage: Does It Explain Resource Use?Jeah Jung, Roger Feldman, Caroline Carlin
Journal of General Internal Medicine|April 13, 2021
Preventable Health Behaviors, COVID-19 Severity Perceptions, and Vaccine Uptake in Traditional Medicare and Medicare Advantage: a Survey-Based StudySungchul Park, Jeah Jung, Eric B Larson
The American Journal of Managed Care|November 1, 2017
In-gap discounts in Medicare Part D and specialty drug useJeah Jung, Wendy Yi Xu, Chelim Cheong
JAMA|June 26, 2023
Medicare Advantage Disenrollment Patterns Among Beneficiaries With Multiple Chronic ConditionsEli Raver, Jeah Jung, Wendy Y Xu
Health Services Research|September 15, 2022
Effects of Medicare eligibility and enrollment at age 65 years on the use of high-value and low-value careSungchul Park, Rishi K Wadhera, Jeah Jung
Health Services Research|January 11, 2024
The mechanics of risk adjustment and incentives for coding intensity in MedicareCaroline S Carlin, Roger Feldman, Jeah Jung
Health Services Research|January 23, 2018
Impact of the 340B Drug Pricing Program on Cancer Care Site and Spending in MedicareJeah Jung, Wendy Y Xu, Yamini Kalidindi
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Health Services Research|September 12, 2021
Measuring resource use in Medicare Advantage using Encounter dataJeah Jung, Caroline Carlin, Roger Feldman
The American Journal of Managed Care|June 19, 2019
Cancer care spending and use by site of provider-administered chemotherapy in MedicareAndrew Shooshtari, Yamini Kalidindi, Jeah Jung
The American Journal of Managed Care|October 17, 2018
The authors respond and stand behind their findingsYamini Kalidindi, Jeah Jung, Roger Feldman
Medical Care Research and Review : MCRR|August 5, 2023
Coding Intensity Through Health Risk Assessments and Chart Reviews in Medicare Advantage: Does It Explain Resource Use?Jeah Jung, Roger Feldman, Caroline Carlin
Journal of General Internal Medicine|April 13, 2021
Preventable Health Behaviors, COVID-19 Severity Perceptions, and Vaccine Uptake in Traditional Medicare and Medicare Advantage: a Survey-Based StudySungchul Park, Jeah Jung, Eric B Larson
The American Journal of Managed Care|November 1, 2017
In-gap discounts in Medicare Part D and specialty drug useJeah Jung, Wendy Yi Xu, Chelim Cheong
JAMA|June 26, 2023
Medicare Advantage Disenrollment Patterns Among Beneficiaries With Multiple Chronic ConditionsEli Raver, Jeah Jung, Wendy Y Xu
Health Services Research|September 15, 2022
Effects of Medicare eligibility and enrollment at age 65 years on the use of high-value and low-value careSungchul Park, Rishi K Wadhera, Jeah Jung
Health Services Research|January 11, 2024
The mechanics of risk adjustment and incentives for coding intensity in MedicareCaroline S Carlin, Roger Feldman, Jeah Jung
Health Services Research|January 23, 2018
Impact of the 340B Drug Pricing Program on Cancer Care Site and Spending in MedicareJeah Jung, Wendy Y Xu, Yamini Kalidindi
Pageof 6